Both the BPQDs@HSA- and X-ray irradiation-treated HepG-2 xenograft models displayed greater penetration of NK cells in tumor tissues, resulting in a significant tumor inhibition rate of up to 81.1% (Figure 11F). The gene discussed is ALB; the disease is neoplasm.